Research led by scientists at the University of California, San Diego (UCSD) School of Medicine has identified a target with potential as an effective new therapy for chronic spasticity and rigidity, ...
Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate
LA JOLLA, CA, June 20, 2008 – A Webinar hosted by TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) at 11 a.m. EDT on June 25 will bring together industry experts to discuss the opportunity of treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results